We are presenting our data at the DDR inhibitor summit, January 24 – 26, 2023, Boston, US
We are excited to hear about the newest progress in the DDR field and look forward to all interesting
discussions.
One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
